Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro López Neyra

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Anales De Pediatria|April 5, 2024
Severe asthma resistant to biological treatment?Marta Bascuas Arribas, María Camino Serrano, Verónica Sanz Santiago, et al.
Atencion Primaria|July 10, 2012
[Patient preferences in primary care]Antonio Luis Aguilar-Shea, Alejandro López Neyra, Javier Aranda Hernández, et al.
Archivos Argentinos De Pediatria|November 8, 2013
Assessing the measurement of airway resistance by the interrupter techniqueYolanda Zuriarrain Reyna, Alejandro López Neyra, Verónica Sanz Santiago, et al.
Archivos De Bronconeumologia|March 20, 2025
Evaluation of the Impact of Elexacaftor/Tezacaftor/Ivacaftor on Aerobic Capacity in Children With Cystic Fibrosis Aged 6-11 Years: Actual Observations and Clinical PerspectivesMargarita Pérez-Ruiz, Mats Te Bos, Patricia Fernández-García, et al.
Children (Basel, Switzerland)|July 29, 2025
Respiratory Muscle Function in Children and Adolescents with Cystic Fibrosis in the Era of CFTR Modulator TherapiesGuillermo García-Pérez-de-Sevilla, Ángela Blanco Velasco, Thomas Yvert, et al.
The Journal of Nutritional Biochemistry|November 11, 2018
A comprehensive evaluation of omega-3 fatty acid supplementation in cystic fibrosis patients using lipidomicsÓscar Pastor, Paula Guzmán-Lafuente, Jorge Serna, et al.
Current Protocols|September 18, 2025
Strength-Oriented Virtual Exercise Training Intervention in Children and Adolescents with Cystic Fibrosis Under CFTR Modulators (the FIQMODE Study): Study Protocol for a Randomized Controlled TrialLisset Pantoja-Arévalo, Thomas Yvert, Tamara Iturriaga, et al.
The European Respiratory Journal|June 4, 2026
Home-based remotely-supervised high-intensity interval training and cardiorespiratory fitness in children and adolescents with post-infectious bronchiolitis obliterans: a randomized controlled trialFernanda Salazar-Pérez, Verónica Sanz-Santiago, Inés de Mir-Messa, et al.
ERJ Open Research|December 3, 2025
Cardiorespiratory fitness in patients with post-infectious bronchiolitis obliterans: a cross-sectional studyFernanda Salazar-Pérez, Verónica Sanz-Santiago, Inés de Mir-Messa, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 10, 2020
Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trialAlejandro López-Neyra, Lucrecia Suárez, Marta Muñoz, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Anales De Pediatria|April 5, 2024
Severe asthma resistant to biological treatment?Marta Bascuas Arribas, María Camino Serrano, Verónica Sanz Santiago, et al.
Atencion Primaria|July 10, 2012
[Patient preferences in primary care]Antonio Luis Aguilar-Shea, Alejandro López Neyra, Javier Aranda Hernández, et al.
Archivos Argentinos De Pediatria|November 8, 2013
Assessing the measurement of airway resistance by the interrupter techniqueYolanda Zuriarrain Reyna, Alejandro López Neyra, Verónica Sanz Santiago, et al.
Archivos De Bronconeumologia|March 20, 2025
Evaluation of the Impact of Elexacaftor/Tezacaftor/Ivacaftor on Aerobic Capacity in Children With Cystic Fibrosis Aged 6-11 Years: Actual Observations and Clinical PerspectivesMargarita Pérez-Ruiz, Mats Te Bos, Patricia Fernández-García, et al.
Children (Basel, Switzerland)|July 29, 2025
Respiratory Muscle Function in Children and Adolescents with Cystic Fibrosis in the Era of CFTR Modulator TherapiesGuillermo García-Pérez-de-Sevilla, Ángela Blanco Velasco, Thomas Yvert, et al.
The Journal of Nutritional Biochemistry|November 11, 2018
A comprehensive evaluation of omega-3 fatty acid supplementation in cystic fibrosis patients using lipidomicsÓscar Pastor, Paula Guzmán-Lafuente, Jorge Serna, et al.
Current Protocols|September 18, 2025
Strength-Oriented Virtual Exercise Training Intervention in Children and Adolescents with Cystic Fibrosis Under CFTR Modulators (the FIQMODE Study): Study Protocol for a Randomized Controlled TrialLisset Pantoja-Arévalo, Thomas Yvert, Tamara Iturriaga, et al.
The European Respiratory Journal|June 4, 2026
Home-based remotely-supervised high-intensity interval training and cardiorespiratory fitness in children and adolescents with post-infectious bronchiolitis obliterans: a randomized controlled trialFernanda Salazar-Pérez, Verónica Sanz-Santiago, Inés de Mir-Messa, et al.
ERJ Open Research|December 3, 2025
Cardiorespiratory fitness in patients with post-infectious bronchiolitis obliterans: a cross-sectional studyFernanda Salazar-Pérez, Verónica Sanz-Santiago, Inés de Mir-Messa, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 10, 2020
Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trialAlejandro López-Neyra, Lucrecia Suárez, Marta Muñoz, et al.
Pageof 2